#$%^&*AU2013224763B220160630.pdf#####14 AHer lniIcn vcaNRPOnlhDCC AAR 54194] .DOC-26/H0/2013 ABSTRACT The present invention provides materials and method for modulating FATP expression and/or activity in vivo. The materials and methods have numerous diagnostic, prophylactic, and therapeutic applications for various diseases and conditions that are influenced by FATPs, or characterized by excessive or inadequate FATP expression or activity. - 69a-